Hospital Particular do Algarve – Alvor reinforces its commitment to innovation and clinical excellence by offering a minimally invasive and highly effective treatment for atrial fibrillation: electroporation ablation.
This procedure represents a significant advancement in the management of cardiac arrhythmias, using cutting-edge technology that allows selective ablation of myocardial tissue. Electroporation stands out for its high safety profile, reducing the risk of injury to surrounding structures and providing greater precision in treatment. Additionally, it allows a reduction in fluoroscopy (X-ray) times, making the procedure more efficient and less invasive for the patient.
The new technique is performed by the Cardiac Electrophysiology/Arrhythmology medical team. This technological advancement strengthens Hospital Particular do Algarve – Alvor’s ability to offer state-of-the-art treatments, focusing on patient safety, efficacy, and comfort.
Atrial fibrillation is the most common cardiac arrhythmia, affecting 1 in 4 adults over the age of 40. It is characterised by irregular and rapid heartbeats, which can cause fatigue, shortness of breath, and significantly increase the risk of stroke and heart failure. Appropriate treatment is essential to improve quality of life and prevent serious complications.
With this new therapeutic approach, Hospital Particular do Algarve – Alvor reaffirms its role as a reference in cardiovascular medicine, offering patients the best in medical innovation.
Dr. Gustavo da Rocha Rodrigues
Arrhythmologist | OM54800
